Trial intelligence / Profile preview

Local anesthetic in endotracheal tube cuff for emergence reactions

IRCT20120910010800N4Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Apr 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of ropivacaine in cough, Post-extubation sore throat (POST) and dysphonia, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Post-extubation cough, Post-extubation sore throat and 1 more. Started Apr 2022; status: completed.

02

Drugs

ropivacaine
03

Conditions

coughPost-extubation sore throat (POST)dysphonia

Beyond the preview

Go deeper on IRCT20120910010800N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120910010800N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call